A New Pathway of Discovery and Career Advancement
Stack Family Center for Biopharmaceutical Education and Training (CBET) is the first center of its kind established by a traditional pharmacy and health sciences college in the United States. It is a strategic extension of the academic programs at ACPHS that creates a new career pathway for students who are passionate about improving the human condition with advanced therapeutics that are made using biological systems—drugs called biopharmaceuticals.
This new pathway merges ACPHS’s rigorous curriculum in human biology, the processes of human diseases, drug design and development, with the fundamentals of bioprocessing and hands-on laboratory experiences in a modern biomanufacturing center that matches industry standards.
Youth programs play a vital role in shaping the future of STEM careers, research and discoveries. CBET’s youth programs provide an opportunity for children to explore their interests, discover their passions, and build valuable relationships with peers and mentors. Values like teamwork, resilience, and empathy, empower young people to become responsible, active, and compassionate members of society. By investing in youth programs, we invest in the potential of our future leaders, equipping them with the tools they need to thrive and make positive contributions to their communities and the world at large.
CBET’s children’s programming includes classroom visits from one of our scientists, hands-on classroom demonstrations, tours of the CBET laboratories and fun summer camps.
Partner with us today to promote the next generation of STEM leaders.
Stack Family Center for Biopharmaceutical Education and Training (CBET) is a core resource for undergraduate students enrolled in the Department of Pharmaceutical Sciences, and the Department of Basic and Clinical Sciences. Current bachelor’s degree programs that include significant course and laboratory work at CBET are:
- BSc in Microbiology with a concentration in Industrial Microbiology
- BSc in Pharmaceutical Sciences with a concentration in Bioanalytics
In 2020 ACPHS established a new Professional Science Master’s in Bioprocessing and Biomanufacturing (MBB). This one-year, non-thesis program, is designed for early and mid-career professionals who want to gain hands-on skills for direct entry into the dynamic biopharmaceutical industry.
ACPHS also offers a traditional M.S. in Pharmaceutical Sciences, as a two-year degree program that provides foundational coursework in the areas of pharmacology, medicinal chemistry, pharmaceutics, toxicology, and pharmacokinetics. Students in this program may take multiple electives at Stack Family Center for Biopharmaceutical Education and Training (CBET).
Doctor of Pharmacy
Students enrolled in the Pharm.D. program at ACPHS can take electives at the Stack Family Center for Biopharmaceutical Education and Training (CBET) to broaden their knowledge of biopharmaceutical development, manufacturing and formulation. Their work at CBET will give Pharm.D. graduates a significant advantage in their career trajectory, especially for those considering clinical and industry positions.
Our fellowship program is the gateway for postgraduate PharmDs and PhDs to experience and explore the biopharmaceutical industry’s diverse working environment. It is both exciting and challenging. Graduates of fellowship programs are highly desirable for their technical expertise, their interpersonal skills, and their understanding of how the business of drug discovery, development, and commercialization occurs on both a domestic and global scale. The Fellow work with the Industry Sponsor in discovery, development, and commercialization of medical products on a real time basis while interacting with healthcare providers, scientists, and regulatory experts.
Be the first to know about new Contract Services and Workforce Training programs and all the latest info on how the Stack Family Center for Biopharmaceutical Education and Training is powering the careers of students and the future workforce needs of biotech companies.